Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rascon

Showing results (191-200 of 194) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 194 results.
Bone Marrow Transplantation|March 24, 2020
Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP studyAndre Manfred Willasch, Christina Peters, Petr Sedláček, et al.
Bone Marrow Transplantation|August 20, 2021
Correction: Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP studyAndre Manfred Willasch, Christina Peters, Petr Sedláček, et al.
Frontiers in Immunology|July 14, 2020
The Clinical and Genetic Spectrum of 82 Patients With <i>RAG</i> Deficiency Including a c.256_257delAA Founder Variant in Slavic CountriesSvetlana O Sharapova, Małgorzata Skomska-Pawliszak, Yulia A Rodina, et al.
Pediatric Transplantation|June 27, 2026
Antimicrobial Prophylaxis in Solid Organ and Hematopoietic Stem Cell Transplantation: A Survey Among Member Centers of the European Reference Network TransplantChildDaniele Donà, Cecilia Liberati, Enrico Aidala, et al.
Pageof 20

Showing results (191-200 of 194) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 194 results.
Bone Marrow Transplantation|March 24, 2020
Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP studyAndre Manfred Willasch, Christina Peters, Petr Sedláček, et al.
Bone Marrow Transplantation|August 20, 2021
Correction: Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?-A multicenter EBMT-PDWP studyAndre Manfred Willasch, Christina Peters, Petr Sedláček, et al.
Frontiers in Immunology|July 14, 2020
The Clinical and Genetic Spectrum of 82 Patients With <i>RAG</i> Deficiency Including a c.256_257delAA Founder Variant in Slavic CountriesSvetlana O Sharapova, Małgorzata Skomska-Pawliszak, Yulia A Rodina, et al.
Pediatric Transplantation|June 27, 2026
Antimicrobial Prophylaxis in Solid Organ and Hematopoietic Stem Cell Transplantation: A Survey Among Member Centers of the European Reference Network TransplantChildDaniele Donà, Cecilia Liberati, Enrico Aidala, et al.
Pageof 20